Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD GlobeNewswire January 12, 2026 SOMERVILLE, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) — Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing(TM), today announced that the U.S. Food and Drug […]

P10 Announces Upcoming Name Change GlobeNewswire January 12, 2026 DALLAS, Jan. 12, 2026 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, today announced it will change its name to Ridgepost Capital, Inc. The name change will become effective on February 11, 2026. Starting that day, the Company's stock

Canada's Biggest Popcorn Celebration: Cineplex Expands National Popcorn Day to Four Days Scene+ Members Score a Free Small Popcorn with a Valid Movie Ticket from January 16-19, 2026 GlobeNewswire January 12, 2026 TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Cineplex, Canada's leading entertainment and media company, is turning National Popcorn Day into a blockbuster celebration.

Oatly to Report Fourth Quarter 2025 Financial Results on February 11, 2026 GlobeNewswire January 12, 2026 MALMÖ, Sweden, Jan. 12, 2026 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY), the world's original and largest oat drink company, will report financial results for the fourth quarter ended December 31, 2025, on Wednesday February 11, 2026 before

GXO Schedules Fourth Quarter, Full-Year 2025 Earnings Conference Call for Wednesday, February 11, 2026 GlobeNewswire January 12, 2026 GREENWICH, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO) will hold its fourth quarter and full-year 2025 earnings conference call and webcast on Wednesday, February 11, 2026, at 8:30 a.m. Eastern Time. The

Village Farms International Advances New Product Innovation in the Dutch Market GlobeNewswire January 12, 2026 Product portfolio expansion aligns with legacy market consumer preferences and global shift toward convenience 10 new product offerings include the first regulated blunt in market as well as infused spliffs and other pre-roll formats DRACHTEN, The Netherlands, Jan. 12, 2026

Gaming and Leisure Properties, Inc. Schedules Fourth Quarter 2025 Earnings Release and Conference Call GlobeNewswire January 12, 2026 WYOMISSING, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) announced today that the Company will release its 2025 fourth quarter financial results after the market close on Thursday, February 19, 2026.

Lyra Therapeutics Provides Corporate Update GlobeNewswire January 12, 2026 WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”) today announced that its Board of Directors has decided to suspend further development of LYR-210, the Company's lead product candidate for the treatment of chronic rhinosinusitis (CRS). The Company

RAD Increases Ownership in Radiopharm Ventures to 87.5% GlobeNewswire January 12, 2026 Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm Theranostics Leading candidate Betabart, a monoclonal antibody targeting B7H3, has received FDA IND clearance for a Phase I therapeutic trial in multiple solid tumors expected to

Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026 GlobeNewswire January 12, 2026 Tanruprubart MAA Filed with Potential to Be the First Targeted Fast-Acting Therapy for Guillain-Barre Syndrome (GBS); BLA Submission with U.S./European Data Planned in 2026 Vonaprument Pivotal Phase 3 Topline Data for Dry AMD